Skip to main content
MCK
NYSE Trade & Services

McKesson Q2 FY27: EPS $10.44, Revenue $111.0B; Debt Jumps to $9.2B on MMS Term Loans

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Positive
Importance info
7
Price
$1,060.3
Mkt Cap
$124.686B
52W Low
$723.68
52W High
$1,073.95
52W Position info
47% above low
Off High info
1.3% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

MCK sits 47% above its 52-week low of $723.68.

Summary

McKesson's Q2 FY27 revenue rose 8% to $110,957 million and diluted EPS jumped to $10.44 from $8.92, while total debt rose to $9,208 million on $3.2 billion of Medical-Surgical Solutions term loans and the company closed roughly $2.8 billion of acquisitions in early November.


Key Events · Earnings and Guidance · MCK

  • Q2 Revenue Up 8%, EPS $10.44

    Revenue rose to $110,957 million from $103,150 million and diluted EPS to $10.44 from $8.92; gross profit grew 12% to $3,956 million.

  • Debt Climbs to $9.2B

    Total debt rose to $9,208 million from $6,526 million after $3.2 billion of Medical-Surgical Solutions term loans; quarterly interest expense rose 42% to $105 million.

  • Acquisitions Closed and Pending

    Closed Precision Medicine Group for about $2.25 billion and a Spectrum Vision Partners controlling stake for about $525 million in early November; agreed October 5 to buy a 49% Option Care Health stake for about $1.4 billion, expected to close in the first half of calendar 2027.

  • Noncontrolling Interests Cut Net Income

    Six-month net income attributable to McKesson fell to $1,832 million from $1,894 million as $496 million went to noncontrolling interests, including a $391 million redemption-value adjustment.


Analysis · MCK · Trade & Services

The quarter was strong — revenue up 8% to $110,957 million and diluted EPS up 17% to $10.44 — but the balance sheet is where the story changed. Total debt climbed to $9,208 million from $6,526 million at March 31 after the Medical-Surgical Solutions unit took on $3.2 billion of term loans, pushing interest expense up 42% to $105 million for the quarter. McKesson also closed roughly $2.25 billion for Precision Medicine Group and about $525 million for a controlling stake in Spectrum Vision Partners in early November, and agreed on October 5 to pay about $1.4 billion for a 49% stake in Option Care Health alongside CD&R, expected to close in the first half of calendar 2027. Six-month net income attributable to McKesson slipped to $1,832 million from $1,894 million because $496 million went to noncontrolling interests, including a $391 million redemption-value adjustment tied to the Apollo investment in Medical-Surgical Solutions. Restructuring charges doubled to $221 million for the six months, and the opioid litigation liability came down to $5,163 million after $496 million of payments.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MCK was trading at $1,060.30 on NYSE in the Trade & Services sector, with a market capitalization of approximately $124.7B. The 52-week trading range was $723.68 to $1,073.95. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MCK - Latest Insights

MCK
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1,049.50
Real-time Price: $1,083.89 info
Change: +$34.39 (+3%) info
Market Cap: $125.205B info
MCK
Nov 04, 2026, 4:10 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $1,069.44
Real-time Price: $1,083.89 info
Change: +$14.45 (+1%) info
Market Cap: $125.205B info
MCK
Oct 06, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $915.45
Real-time Price: $1,083.89 info
Change: +$168.44 (+18%) info
Market Cap: $125.205B info
MCK
Oct 05, 2026, 4:03 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $915.96
Real-time Price: $1,083.89 info
Change: +$167.93 (+18%) info
Market Cap: $125.205B info
MCK
Oct 01, 2026, 8:03 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $851.75
Real-time Price: $1,083.89 info
Change: +$232.14 (+27%) info
Market Cap: $125.205B info